Founded in 2002, 5AM Ventures is a leading venture capital firm focused on building next-generation life science companies. With offices in San Francisco and Boston, 5AM takes a hands-on approach to investing and company building, often going beyond traditional board roles to leverage our diverse team of scientists, clinicians, drug developers and executives throughout a company’s life. With over $2.0 billion raised since inception, 5AM has invested globally in 100 public and private companies. For more information, please visit www.5amventures.com.
BioCentury helps C-level biotech executives and investors make business-critical decisions by providing independent deep-dive analysis, high-quality data, and business intelligence on a global scale. We report on and dissect trends before others, helping you to better position your company for change and to capitalize on that change before your competition. No matter where you are in the drug development process—from idea to patient—we help you answer critical questions, decipher strategic trends, objectively evaluate product and business strategies, and assess competitive, financial, and policy risks. For more information, please visit BioCentury.com.
Versant Ventures is a leading healthcare venture capital firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $5.4 billion under management and offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and R&D expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 95 Versant companies have achieved successful acquisitions or IPOs. For more information, please visit www.versantventures.com.
Wilson Sonsini’s legacy of life sciences industry leadership dates back to the formative years of the biotech and medical device sectors, when bold new companies first started to develop important life changing and life saving products and solutions. Since then, the firm has earned its leadership position in the life sciences sector through our representation of innovative companies in the biotechnology, medical devices, and pharmaceuticals sectors, as well as our 40-plus-year history of working closely with the scientists and entrepreneurs who started and grew the companies into thriving businesses. We also have an equally long history of representing sophisticated investors and funding sources that finance entities across the life sciences industry. Today, the firm’s life sciences practice–one of the largest in the U.S.–is anchored by a multi-disciplinary team of more than 275 professionals, including attorneys, patent agents, and scientific advisors. A substantial number of our practitioners have advanced degrees in biology, chemistry, engineering, or other scientific fields. Similarly, a large number of our professionals have experience working in laboratory, medical, or research facilities. The team also includes attorneys who have served as in-house legal counsel for major life sciences companies, or have held senior positions at U.S. federal agencies, including the U.S. Patent and Trademark Office (USPTO) and the Patent Trial and Appeal Board (PTAB).